Mesterolone 10 - Livewell Pharmaceuticals

Schering introduced Mesterolone to the pharmaceutical world in 1934 under the brand name Proviron®. It holds historical importance as the first synthetic oral androgen used in clinical practice. Released during a period when medical science was beginning to explore hormonal therapy, it served as a treatment for male hypogonadism and related conditions. Though relatively weak in anabolic terms, its oral availability and strong androgenic action ensured its place in long-standing therapeutic use. Mesterolone has been distributed globally, even after Schering became part of Bayer in 2006.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Mesterolone 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.